Capricor Therapeutics reported $-7109000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Bluebird Bio BLUE:US USD -76520000 23.62M
Cytokinetics CYTK:US USD -142310000 122.49M
Cytori Therapeutics CYTX:US USD -5219000 63K
Johnson & Johnson JNJ:US USD 4.46B 356M
Newlink Genetics NLNK:US USD -7251000 593K
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Vascular Biogenics VBLT:US USD -9170000 264K
Vital Therapies VTL:US USD -21224000 677K